Outcomes after removing spinal cord gliomas through the dorsolateral sulcus approach
Official title: A Registry-Based Cohort Study on the Clinical Outcomes of Spinal Cord Glioma Resection Via the Dorsolateral Sulcus Approach
Run by Beijing Tiantan Hospital · NCT07066475 · Data updated 2026-11-12
This project will try the dorsolateral sulcus surgical route in patients aged 3–75 with lateral spinal cord gliomas to see if it preserves neurological function, reduces pain, and improves quality of life compared with the traditional midline approach.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 3 Years to 75 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Beijing Tiantan Hospital Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Status | Recruiting |
| Started | January 1, 2022 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | July 23, 2025 |
| Trial ID | NCT07066475 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Patients aged 3–75 with histopathologically confirmed, lateralized spinal cord glioma who are scheduled for surgical resection and can provide consent and attend follow-up visits.
✕Probably not a fit
Patients with centrally located tumors, recent chemo/radiotherapy or immunotherapy within the exclusion windows, uncontrolled medical conditions, pregnancy, or those outside the 3–75 age range are unlikely to benefit or be eligible for the comparison.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, registry-based cohort compares clinical outcomes after intramedullary spinal cord glioma resection performed via the dorsolateral sulcus (DLS) approach versus the posterior median sulcus (PMS) approach. Eligible patients are aged 3–75 with histologically confirmed lateralized spinal cord gliomas and available clinical data for follow-up. Outcomes include pain (VAS), neurological function (McCormick grading and JOA score), SF-36 quality of life, and posterior column functional measures collected preoperatively and at scheduled postoperative time points. The registry will use validated clinical scales to compare postoperative function, complications, and quality-of-life trajectories between the two surgical routes.
Why it matters
Potential benefit: If successful, the dorsolateral sulcus approach could reduce neurological injury, lower pain, and improve postoperative quality of life for patients with lateral spinal cord gliomas.
How similar studies have gone: Preliminary clinical observations suggest the dorsolateral approach may better preserve neurological function, but direct comparative evidence is limited and not yet definitive.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age between 3 and 75 years 2. Undergoing surgical resection of spinal cord tumor 3. Histopathological diagnosis of spinal cord glioma based on routine pathological examination 4. Availability of complete clinical data and willingness to participate in follow-up 5. Informed consent obtained from the patient and/or legal guardians or immediate family members Exclusion Criteria: 1. Age under 3 years or over 75 years 2. Receipt of radiotherapy, chemotherapy, or anti-tumor biological therapy within 1 month prior to enrollment 3. Receipt of immunotherapy within 3 months prior to enrollment 4. Participation in other clinical trials within 3 months prior to enrollment 5. History of severe allergic reactions or known allergy-prone constitution 6. Pregnant or breastfeeding women, or individuals of childbearing potential not using adequate contraception 7. Presence of other severe medical conditions or uncontrolled infections 8. History of drug abuse, substance misuse, chronic alcoholism, or HIV infection 9. Uncontrolled epileptic seizures or psychiatric disorders resulting in loss of self-control
Where it's running
-
Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China Recruiting
Study contacts
- Study coordinator: Wang Yongzhi Wang, MD
- Email: yongzhiwang_bni@163.com
- Phone: +86 13466391736
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intranasal NEO100 for Pediatric Brain Tumors: Safety and Dosing
We’re testing whether delivering NEO100 through the nose is safe and achievable at higher doses for children with certain brain tumors.
-
Combining laser treatment and radiosurgery for spinal tumors
This study is testing if using both laser treatment and targeted radiation can help people with spinal tumors feel better and improve their quality of life compared to just using radiation alone.
-
Implanted Brain-Computer Interface to Help People with Severe Arm Impairment
We’re testing the N1 System, a fully implanted brain interface in the motor cortex with a robot, to see if it can help adults with spinal cord injury, ALS, or chronic stroke use a computer or keyboard more easily.
-
tSCS with rehabilitation for improving movement after spinal cord injury
This study tests whether adding rehabilitation training to transcutaneous spinal cord stimulation helps paraplegic patients regain voluntary movement after spinal cord injury.
-
Informational Needs of Caregivers of Patients in Neuro Rehab: Validating the QBI-R/V
This study tests a caregiver questionnaire (QBI-R and QBI-V) to see how well it measures caregivers’ informational needs during neuromotor rehabilitation.
-
Biomechanical and Perceived Effort in Manual Wheelchair Propulsion
This study tests whether combining objective shoulder loading data with how hard people feel they’re working can reveal how difficult manual wheelchair propulsion is for users with spinal cord injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.